collection
Collections Infectious diseases.

Infectious diseases.

Evidence of MERS-CoV transmission from camels to humans.

https://read.qxmd.com/read/38442248/guide-to-utilization-of-the-microbiology-laboratory-for-diagnosis-of-infectious-diseases-2024-update-by-the-infectious-diseases-society-of-america-idsa-and-the-american-society-for-microbiology-asm
#1
JOURNAL ARTICLE
J Michael Miller, Matthew J Binnicker, Sheldon Campbell, Karen C Carroll, Kimberle C Chapin, Mark D Gonzalez, Amanda Harrington, Robert C Jerris, Sue C Kehl, Sixto M Leal, Robin Patel, Bobbi S Pritt, Sandra S Richter, Barbara Robinson-Dunn, James W Snyder, Sam Telford, Elitza S Theel, Richard B Thomson, Melvin P Weinstein, Joseph D Yao
The critical nature of the microbiology laboratory in infectious disease diagnosis calls for a close, positive working relationship between the physician and the microbiologists who provide enormous value to the health care team. This document, developed by experts in both adult and pediatric laboratory and clinical medicine, provides information on which tests are valuable and in which contexts, and on tests that add little or no value for diagnostic decisions. Sections are divided into anatomic systems, including Bloodstream Infections and Infections of the Cardiovascular System, Central Nervous System Infections, Ocular Infections, Soft Tissue Infections of the Head and Neck, Upper Respiratory Infections, Lower Respiratory Tract infections, Infections of the Gastrointestinal Tract, Intraabdominal Infections, Bone and Joint Infections, Urinary Tract Infections, Genital Infections, and Skin and Soft Tissue Infections; or into etiologic agent groups, including arboviral Infections, Viral Syndromes, and Blood and Tissue Parasite Infections...
March 5, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/36652356/periprosthetic-joint-infection
#2
REVIEW
Robin Patel
New England Journal of Medicine, Volume 388, Issue 3, Page 251-262, January 2023.
January 19, 2023: New England Journal of Medicine
https://read.qxmd.com/read/22567269/tuberculous-meningitis-diagnosis-and-treatment-overview
#3
JOURNAL ARTICLE
Grace E Marx, Edward D Chan
Tuberculous meningitis (TBM) is the most common form of central nervous system tuberculosis (TB) and has very high morbidity and mortality. TBM is typically a subacute disease with symptoms that may persist for weeks before diagnosis. Characteristic cerebrospinal fluid (CSF) findings of TBM include a lymphocytic-predominant pleiocytosis, elevated protein, and low glucose. CSF acid-fast smear and culture have relatively low sensitivity but yield is increased with multiple, large volume samples. Nucleic acid amplification of the CSF by PCR is highly specific but suboptimal sensitivity precludes ruling out TBM with a negative test...
2011: Tuberculosis Research and Treatment
https://read.qxmd.com/read/36195185/need-for-standardised-vancomycin-dosing-for-coagulase-negative-staphylococci-in-hospitalised-infants
#4
JOURNAL ARTICLE
Eleanor J Harvey, Diane Ashiru-Oredope, Louise F Hill, Alicia Demirjian
No abstract text is available yet for this article.
October 1, 2022: Clinical Microbiology and Infection
https://read.qxmd.com/read/34051142/ceftriaxone-compared-with-benzylpenicillin-in-the-treatment-of-neurosyphilis-in-france-a-retrospective-multicentre-study
#5
MULTICENTER STUDY
Thomas Bettuzzi, Aurélie Jourdes, Olivier Robineau, Isabelle Alcaraz, Victoria Manda, Jean Michel Molina, Maxime Mehlen, Charles Cazanave, Pierre Tattevin, Sami Mensi, Benjamin Terrier, Alexis Régent, Jade Ghosn, Caroline Charlier, Guillaume Martin-Blondel, Nicolas Dupin
BACKGROUND: Intravenous benzylpenicillin is the gold-standard treatment for neurosyphilis, but it requires prolonged hospitalisation. Ceftriaxone is a possible alternative treatment, the effectiveness of which remains unclear. We aimed to assess the effectiveness of ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis. METHODS: We did a retrospective multicentre study including patients with neurosyphilis who were treated at one of eight tertiary care centres in France, from Jan 1, 1997, to Dec 31, 2017...
October 2021: Lancet Infectious Diseases
https://read.qxmd.com/read/31307948/efficacy-and-safety-of-dolutegravir-rilpivirine-for-maintenance-of-virological-suppression-in-adults-with-hiv-1-100-week-data-from-the-randomised-open-label-phase-3-sword-1-and-sword-2-studies
#6
RANDOMIZED CONTROLLED TRIAL
Michael Aboud, Chloe Orkin, Daniel Podzamczer, Johannes R Bogner, David Baker, Marie-Aude Khuong-Josses, David Parks, Konstantinos Angelis, Lesley P Kahl, Elizabeth A Blair, Kimberly Adkison, Mark Underwood, Jessica E Matthews, Brian Wynne, Kati Vandermeulen, Martin Gartland, Kimberly Smith
BACKGROUND: Primary analyses of the SWORD-1 and SWORD-2 trials at 48 weeks showed that switching to a two-drug regimen of dolutegravir plus rilpivirine was non-inferior to continuing a standard three-drug or four-drug antiretroviral regimen for maintenance of virological suppression in people with HIV-1. Here, we present efficacy and safety data from the 100-week analysis of the trials. METHODS: SWORD-1 and SWORD-2 are identically designed, randomised, open-label phase 3 studies at 65 centres in 13 countries and 60 centres in 11 countries, respectively...
September 2019: Lancet HIV
https://read.qxmd.com/read/32171740/new-insights-on-the-antiviral-effects-of-chloroquine-against-coronavirus-what-to-expect-for-covid-19
#7
JOURNAL ARTICLE
Christian A Devaux, Jean-Marc Rolain, Philippe Colson, Didier Raoult
Recently, a novel coronavirus (2019-nCoV), officially known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in China. Despite drastic containment measures, the spread of this virus is ongoing. SARS-CoV-2 is the aetiological agent of coronavirus disease 2019 (COVID-19) characterised by pulmonary infection in humans. The efforts of international health authorities have since focused on rapid diagnosis and isolation of patients as well as the search for therapies able to counter the most severe effects of the disease...
May 2020: International Journal of Antimicrobial Agents
https://read.qxmd.com/read/30224533/double-blind-randomized-placebo-controlled-phase-ii-dose-finding-study-to-evaluate-high-dose-rifampin-for-tuberculous-meningitis
#8
RANDOMIZED CONTROLLED TRIAL
S Dian, V Yunivita, A R Ganiem, T Pramaesya, L Chaidir, K Wahyudi, T H Achmad, A Colbers, L Te Brake, R van Crevel, R Ruslami, R Aarnoutse
High doses of rifampin may help patients with tuberculous meningitis (TBM) to survive. Pharmacokinetic pharmacodynamic evaluations suggested that rifampin doses higher than 13 mg/kg given intravenously or 20 mg/kg given orally (as previously studied) are warranted to maximize treatment response. In a double-blind, randomized, placebo-controlled phase II trial, we assigned 60 adult TBM patients in Bandung, Indonesia, to standard 450 mg, 900 mg, or 1,350 mg (10, 20, and 30 mg/kg) oral rifampin combined with other TB drugs for 30 days...
December 2018: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/26565015/when-sepsis-persists-a-review-of-mrsa-bacteraemia-salvage-therapy
#9
REVIEW
Ravina Kullar, George Sakoulas, Stan Deresinski, Sebastiaan J van Hal
MRSA bacteraemia (MRSAB), including infective endocarditis, carries a high mortality rate, with up to 50% of patients failing initial therapy with vancomycin and requiring salvage therapy. Persistent MRSAB can be difficult to successfully eliminate, especially when source control is not possible due to an irremovable focus or the bacteraemia still persists despite surgical intervention. Although vancomycin and daptomycin are the only two antibiotics approved by the US FDA for the treatment of patients with MRSAB as monotherapy, the employment of novel strategies is required to effectively treat patients with persistent MRSAB and these may frequently involve combination drug therapy...
March 2016: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/31855548/visceral-leishmaniasis-northern-somalia-2013-2019
#10
JOURNAL ARTICLE
Mikko K Aalto, Temmy Sunyoto, Mohamed Ahmed Ali Yusuf, Abdiaziz Ahmed Mohamed, Gert Van der Auwera, Jean-Claude Dujardin
We identified visceral leishmaniasis caused by Leishmania donovani in a previously unknown focus in northern Somalia. Clinical and epidemiologic characteristics of 118 cases during 2013-2019 in Bosaso, the region's commercial capital, have raised suspicion of visceral leishmaniasis endemicity status there.
January 2020: Emerging Infectious Diseases
https://read.qxmd.com/read/30796442/oral-fosfomycin-for-the-treatment-of-chronic-bacterial-prostatitis
#11
JOURNAL ARTICLE
Ilias Karaiskos, Lambrini Galani, Vissaria Sakka, Aikaterini Gkoufa, Odysseas Sopilidis, Dimitrios Chalikopoulos, Gerasimos Alivizatos, Eleni Giamarellou
BACKGROUND: Chronic bacterial prostatitis (CBP) is a difficult-to-treat infection as only a few antibiotics achieve therapeutic concentrations in the prostate. Data on the efficacy and safety of oral fosfomycin for the treatment of CBP are limited. OBJECTIVES: To analyse the efficacy and safety of fosfomycin in CBP due to MDR pathogens. METHODS: In a prospective observational study, an oral regimen of 3 g of fosfomycin q24h for 1 week followed by 3 g q48h for a treatment duration of 6-12 weeks was administered...
May 1, 2019: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/30052831/a-case-of-fulminant-endophthalmitis
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 1, 2017: Clinical Infectious Diseases
https://read.qxmd.com/read/29977970/the-cefazolin-inoculum-effect-is-associated-with-increased-mortality-in-methicillin-susceptible-staphylococcus-aureus-bacteremia
#13
JOURNAL ARTICLE
William R Miller, Carlos Seas, Lina P Carvajal, Lorena Diaz, Aura M Echeverri, Carolina Ferro, Rafael Rios, Paola Porras, Carlos Luna, Eduardo Gotuzzo, Jose M Munita, Esteban Nannini, Cesar Carcamo, Jinnethe Reyes, Cesar A Arias
Background: Recent studies have favored the use of cefazolin over nafcillin for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. The clinical influence of the cefazolin inoculum effect (CzIE) in the effectiveness of cephalosporins for severe MSSA infections has not been evaluated. Methods: We prospectively included patients from 3 Argentinian hospitals with S. aureus bacteremia. Cefazolin minimum inhibitory concentrations (MICs) were determined at standard (105 colony-forming units [CFU]/mL) and high (107 CFU/mL) inoculum...
June 1, 2018: Open Forum Infectious Diseases
https://read.qxmd.com/read/29710295/effect-of-5-day-nitrofurantoin-vs-single-dose-fosfomycin-on-clinical-resolution-of-uncomplicated-lower-urinary-tract-infection-in-women-a-randomized-clinical-trial
#14
RANDOMIZED CONTROLLED TRIAL
Angela Huttner, Anna Kowalczyk, Adi Turjeman, Tanya Babich, Caroline Brossier, Noa Eliakim-Raz, Katarzyna Kosiek, Begoña Martinez de Tejada, Xavier Roux, Shachaf Shiber, Ursula Theuretzbacher, Elodie von Dach, Dafna Yahav, Leonard Leibovici, Maciek Godycki-Cwirko, Johan W Mouton, Stephan Harbarth
IMPORTANCE: The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for lower urinary tract infection (UTI). OBJECTIVE: To compare the clinical and microbiologic efficacy of nitrofurantoin and fosfomycin in women with uncomplicated cystitis. DESIGN, SETTING, AND PARTICIPANTS: Multinational, open-label, analyst-blinded, randomized clinical trial including 513 nonpregnant women aged 18 years and older with symptoms of lower UTI (dysuria, urgency, frequency, or suprapubic tenderness), a positive urine dipstick result (with detection of nitrites or leukocyte esterase), and no known colonization or previous infection with uropathogens resistant to the study antibiotics...
May 1, 2018: JAMA
https://read.qxmd.com/read/26327198/rapid-diagnosis-of-infection-in-the-critically-ill-a-multicenter-study-of-molecular-detection-in-bloodstream-infections-pneumonia-and-sterile-site-infections
#15
MULTICENTER STUDY
Jean-Louis Vincent, David Brealey, Nicolas Libert, Nour Elhouda Abidi, Michael O'Dwyer, Kai Zacharowski, Malgorzata Mikaszewska-Sokolewicz, Jacques Schrenzel, François Simon, Mark Wilks, Marcus Picard-Maureau, Donald B Chalfin, David J Ecker, Rangarajan Sampath, Mervyn Singer
OBJECTIVE: Early identification of causative microorganism(s) in patients with severe infection is crucial to optimize antimicrobial use and patient survival. However, current culture-based pathogen identification is slow and unreliable such that broad-spectrum antibiotics are often used to insure coverage of all potential organisms, carrying risks of overtreatment, toxicity, and selection of multidrug-resistant bacteria. We compared the results obtained using a novel, culture-independent polymerase chain reaction/electrospray ionization-mass spectrometry technology with those obtained by standard microbiological testing and evaluated the potential clinical implications of this technique...
November 2015: Critical Care Medicine
https://read.qxmd.com/read/24484653/nontuberculous-mycobacterial-ntm-lung-disease-the-top-ten-essentials
#16
REVIEW
Timothy R Aksamit, Julie V Philley, David E Griffith
This review will utilize essential questions about nontuberculous mycobacterial (NTM) lung disease to succinctly address important new developments in the pathogenesis, diagnosis and management of NTM lung disease with a focus on practical information and "bottom line" answers. 1) What do I tell my patients who ask, “where did I get this infection” and, “should I take showers”? 2) What is the connection between bronchiectasis and the acquisition of NTM lung infection? 3) What other factors are important in the pathogenesis of NTM lung disease? 4) Why does it seem that am I seeing more new NTM lung disease patients? 5) Why is the diagnosis of NTM lung disease so complicated and does the diagnosis of NTM lung infection obligate specific treatment? 6) Unlike traditional tuberculosis, what is behind the irrelevance of most in vitro susceptibility testing reports for NTM infections? 7) Is there anything new for the management of patients with Mycobacterium avium complex lung disease? How does the radiographic appearance influence treatment? 8) Is there anything new for the management of patients with Mycobacterium abscessus lung disease? 9) What about the management of other NTM respiratory pathogens? 10) Is there a role for the use of macrolide monotherapy for non-cystic fibrosis bronchiectasis?...
March 2014: Respiratory Medicine
https://read.qxmd.com/read/26968696/parasitic-contamination-of-fresh-vegetables-sold-at-central-markets-in-khartoum-state-sudan
#17
JOURNAL ARTICLE
Mona Ali Mohamed, Emmanuel Edwar Siddig, Arwa Hassan Elaagip, Ali Mahmoud Mohammed Edris, Awad Ahmed Nasr
BACKGROUND: Fresh vegetables are considered as vital nutrients of a healthy diet as they supply the body with essential supplements. The consumption of raw vegetables is the main way for transmission of intestinal parasitic organisms. This study was aimed at detecting the parasitic contamination in fresh vegetables sold in two central open-aired markets in Khartoum state, Sudan. METHODS: In this prospective cross-sectional study, a total of 260 fresh vegetable samples and 50 water samples used to sprinkle vegetable(s) were collected from two central open-aired markets (namely; Elshaabi and Central markets) during November 2011 to May 2012...
March 11, 2016: Annals of Clinical Microbiology and Antimicrobials
https://read.qxmd.com/read/27071986/a-pilot-study-to-assess-bacterial-and-toxin-reduction-in-patients-with-clostridium-difficile-infection-given-fidaxomicin-or-vancomycin
#18
JOURNAL ARTICLE
Abrar K Thabit, M Jahangir Alam, Mohammed Khaleduzzaman, Kevin W Garey, David P Nicolau
BACKGROUND: To assess the effect of fidaxomicin and vancomycin on Clostridium difficile toxins and correlation with clinical and microbiologic outcomes. METHODS: Hospitalized patients with C. difficile infection were randomly assigned a 10-day course of fidaxomicin or vancomycin. Stool samples collected at baseline (day 0), mid-therapy (days 3-5), end of therapy (days 10-13) and follow-up (days 19-38) were assessed for quantity of toxins A and B as well as spore and vegetative cells counts...
April 12, 2016: Annals of Clinical Microbiology and Antimicrobials
https://read.qxmd.com/read/12847550/genetic-susceptibility-to-visceral-leishmaniasis-in-the-sudan-linkage-and-association-with-il4-and-ifngr1
#19
JOURNAL ARTICLE
H S Mohamed, M E Ibrahim, E N Miller, C S Peacock, E A G Khalil, H J Cordell, J M M Howson, A M El Hassan, R E H Bereir, J M Blackwell
Longitudinal studies in Sudan show ethnic differences in incidence and clinical phenotypes associated with Leishmania donovani. Immunologically, bias in type 1 vs type 2 cytokine responses is important. To determine whether polymorphisms at IL4/IL9 or IFNGR1 contribute to susceptibility, we examined 59 multicase families of visceral leishmaniasis (VL) with/without post Kala-azar dermal leishmaniasis (PKDL). Multipoint nonparametric analysis (Allegro) linked IL4/IL9 to VL per se (P=0.002). Transmission disequilibrium testing with robust variance estimates confirmed association in the presence of linkage between VL per se and IL4 (P=0...
July 2003: Genes and Immunity
https://read.qxmd.com/read/26994090/efficacy-of-ceftolozane-tazobactam-versus-levofloxacin-in-the-treatment-of-complicated-urinary-tract-infections-cutis-caused-by-levofloxacin-resistant-pathogens-results-from-the-aspect-cuti-trial
#20
RANDOMIZED CONTROLLED TRIAL
Jennifer A Huntington, George Sakoulas, Obiamiwe Umeh, Daniel J Cloutier, Judith N Steenbergen, Caleb Bliss, Ellie J C Goldstein
OBJECTIVES: Empirical fluoroquinolone therapy is widely used in treating complicated urinary tract infections (cUTIs), even in areas of high fluoroquinolone resistance. While it is believed that high antibiotic concentrations in urine might be sufficient to overcome and effectively treat infections caused by resistant bacteria, clinical trial data validating this assumption are limited. This post hoc analysis evaluated the efficacy of ceftolozane/tazobactam versus levofloxacin in the subgroup of patients with cUTIs caused by levofloxacin-resistant pathogens in a randomized, controlled trial (NCT01345929/NCT01345955)...
July 2016: Journal of Antimicrobial Chemotherapy
label_collection
label_collection
2148
1
2
2016-03-29 21:58:49
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.